Lalan Middle East LLC, a subsidiary of Sri Lanka Lalan Group, has announced its second phase of expansion at the Sohar Freezone with an investment of approximately $12 million, securing an additional 7,500 sqm of land at SOHAR Freezone to further strengthen its medical device manufacturing and integrated service capabilities in the Sultanate.
Established in 2019 as a General Trading License (GTL) company in the SOHAR Freezone, Lalan Middle East developed its first medical device manufacturing facility, equipped with certified cleanroom packing facilities, a microbiology laboratory and an Ethylene Oxide (EO) sterilization plant, which was inaugurated in February 2026.
Since commencing operations, Lalan Middle East has successfully established its presence in the local market while rapidly expanding exports to the GCC. The company currently contributes over RO2 million annually in In-Country Value (ICV) and has achieved an Omanization rate of over 30%, reflecting its commitment to local economic development and employment.
Commenting on the expansion plans Damith De Alwis, Director of Lalan Middle East said; “We have had great support in Oman from all our partners and key government entities. They have facilitated and encouraged our business since the inception. We are confident in Oman, its potential and its strategic advantages in the region. We hope to continue our expansion efforts further and support Oman’s vision in establishing a medical device manufacturing and integrated service ecosystem.
The second phase of investment for Lalan Middle East represents a significant milestone in their long term growth strategy in Oman. The expansion will focus on diversifying its medical device portfolio, developing downstream manufacturing capabilities, increasing temperature controlled warehousing capacity and expanding its microbiology laboratory facilities.
Beyond increasing operational capacity, the investment aims to establish an integrated medical device manufacturing and services ecosystem, supporting both local and international manufacturers through specialized infrastructure, technical expertise and certified services under Oman Ministry of Health’s’ GMP, ISO13485, ISO11135, CE and US – FDA.
A key priority of this expansion is the creation of sustainable employment opportunities for Omani nationals. The company intends to invest in workforce development and specialized technical training, building a pool of skilled Omani professionals with experience in internationally recognized medical device quality management standards, including ISO 13485 in parallel with their expansion plans.
Aligned with Oman Vision 2040, Lalan Middle East's expansion reinforces its commitment to supporting economic diversification, industrial development, in country value creation and the development of a knowledge-based workforce.
By strengthening domestic medical device manufacturing and providing integrated services encompassing cleanroom operations, sterilization, microbiological testing and specialized warehousing, Lalan aims to contribute towards enhancing Oman's healthcare supply chain resilience and position the Sultanate as a competitive regional hub for medical device manufacturing and exports.
The investment also reflects Lalan Group's long term confidence in Oman as a strategic destination for industrial investment and regional growth.
Oman Observer is now on the WhatsApp channel. Click here
